These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22838092)

  • 1. CD4+ CD56+ hematodermic neoplasm and plasmacytoid dendritic cell tumor: case report and review of the literature.
    Campbell SM; Moad JC; Sammons DL; Zirwas M
    Cutis; 2012 Jun; 89(6):278-83. PubMed ID: 22838092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.
    Petrella T; Meijer CJ; Dalac S; Willemze R; Maynadié M; Machet L; Casasnovas O; Vergier B; Teitell MA
    Am J Clin Pathol; 2004 Aug; 122(2):307-13. PubMed ID: 15323148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ CD56+ hematodermic neoplasm.
    Cibull TL; Thomas AB; O'Malley DP; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):59-61. PubMed ID: 17284963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+/CD56+ hematodermic neoplasm: presentation of 2 cases and review of the concept of an uncommon tumor originated in plasmacytoid dendritic cells expressing CD123 (IL-3 receptor alpha).
    Piña-Oviedo S; Herrera-Medina H; Coronado H; Del Valle L; Ortiz-Hidalgo C
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):481-6. PubMed ID: 18091395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+/CD56+ haematodermic neoplasm: a preculsor haematological neoplasm that frequently first presents in the skin.
    Martín JM; Nicolau MJ; Galán A; Ferrández-Izquierdo A; Ferrer AM; Jordá E
    J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1129-32. PubMed ID: 16987271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of CD4+/CD56+ hematodermic neoplasm (plasmacytoid dendritic cell neoplasm).
    Su O; Onsun N; Demirkesen C; Aydin Y; Pirmit S; Gereli M
    Dermatol Online J; 2010 Apr; 16(4):8. PubMed ID: 20409415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin manifestations in CD4+, CD56+ malignancies.
    Penven K; Macro M; Salaun V; Comoz F; Reman O; Leroy D; Troussard X; Petrella T; Dompmartin A
    Eur J Dermatol; 2003; 13(2):161-5. PubMed ID: 12695132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous CD4+ CD56+ hematologic malignancies.
    Magro CM; Porcu P; Schaefer J; Erter JW; Furman RR; Shitabata PK; Crowson AN
    J Am Acad Dermatol; 2010 Aug; 63(2):292-308. PubMed ID: 20541283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.
    Herling M; Jones D
    Am J Clin Pathol; 2007 May; 127(5):687-700. PubMed ID: 17439829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic review.
    Shi Y; Wang E
    Arch Pathol Lab Med; 2014 Apr; 138(4):564-9. PubMed ID: 24678689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype.
    Urosevic M; Conrad C; Kamarashev J; Asagoe K; Cozzio A; Burg G; Dummer R
    Hum Pathol; 2005 Sep; 36(9):1020-4. PubMed ID: 16153467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blastic plasmacytoid dendritic cell neoplasm revealed by ecchymotic lesions on the face].
    Ahogo KC; Wantz M; Cliquennois M; Gosset P; Lebas D; Modiano P
    Ann Dermatol Venereol; 2014 Jan; 141(1):43-7. PubMed ID: 24461094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of CD123, CD56 and CD4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm.
    Hwang K; Park CJ; Jang S; Chi HS; Huh JR; Lee JH; Suh C; Lee KH
    Histopathology; 2013 Apr; 62(5):764-70. PubMed ID: 23470050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cutaneous blastic plasmacytoid dendritic cell neoplasm without extracutaneous manifestation: case report and review of the literature.
    Li Y; Li Z; Lin HL; Chen XH; Li B
    Pathol Res Pract; 2011 Jan; 207(1):55-9. PubMed ID: 20573459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate.
    Leitenberger JJ; Berthelot CN; Polder KD; Pro B; McLaughlin P; Jones D; Duvic M
    J Am Acad Dermatol; 2008 Mar; 58(3):480-4. PubMed ID: 18280345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blastic plasmacytoid dendritic cell neoplasm: a report of four cases and review of the literature.
    Borchiellini D; Ghibaudo N; Mounier N; Del Giudice P; Quinsat D; Ticchioni M; Perrin C; Cardot Leccia N; Lacour JP
    J Eur Acad Dermatol Venereol; 2013 Sep; 27(9):1176-81. PubMed ID: 22455538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases.
    Ng AP; Lade S; Rutherford T; McCormack C; Prince HM; Westerman DA
    Haematologica; 2006 Jan; 91(1):143-4. PubMed ID: 16434387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hematodermic CD4+ CD56+ neoplasm in childhood].
    Bilbao EA; Chirife AM; Florio D; Giménez LB; Marino L; Rosso DA
    Medicina (B Aires); 2008; 68(2):147-50. PubMed ID: 18499965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon.
    Pilichowska ME; Fleming MD; Pinkus JL; Pinkus GS
    Am J Clin Pathol; 2007 Sep; 128(3):445-53. PubMed ID: 17709319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of blastic plasmacytoid dendritic cell neoplasm: cytomorphological findings of the touch imprint specimen of lymph node.
    Nakatsuka S; Nagano T; Kimura H; Nagatomo T; Urase Y; Hashimoto K
    Diagn Cytopathol; 2013 Jan; 41(1):67-70. PubMed ID: 22241735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.